Get the Stockscreener App
66.63
1.08%
-0.73
Solventum Corp stock is traded at $66.63, with a volume of 1.34M.
It is down -1.08% in the last 24 hours and up +3.54% over the past month.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
See More
Previous Close:
$67.36
Open:
$66.94
24h Volume:
1.34M
Relative Volume:
1.07
Market Cap:
$11.55B
Revenue:
$8.35B
Net Income/Loss:
$1.56B
P/E Ratio:
7.5086
EPS:
8.8738
Net Cash Flow:
$-4.00M
1W Performance:
-2.76%
1M Performance:
+3.54%
6M Performance:
-3.49%
1Y Performance:
+1.54%
1-Day Range:
$66.36
$67.52
1-Week Range:
$65.44
$70.03
52-Week Range:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
66.63 | 11.55B | 8.35B | 1.56B | -4.00M | 8.8738 |
ISRG
Intuitive Surgical Inc
|
457.78 | 162.13B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
149.31 | 42.47B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
44.75 | 37.84B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.09 | 36.11B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
205.02 | 29.87B | 5.40B | 1.49B | 1.78B | 10.12 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-24-26 | Initiated | Rothschild & Co Redburn | Sell |
| Jan-26-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-20-26 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
SOLV SEC FilingsSolventum Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
Health Industry Shakeup: From Solventum Overhaul to Breast Cancer Drug Approvals - Devdiscourse
US Bancorp DE Has $35.23 Million Holdings in Solventum Corporation $SOLV - MarketBeat
Trian’s Push For Cuts And Buybacks Might Change The Case For Investing In Solventum (SOLV) - simplywall.st
Solventum gains after activist Trian sends letter urging changes (update) - MSN
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
Solventum (SOLV) director settles 3,403 RSUs into Common Stock - Stock Titan
[Form 4] Solventum Corp Insider Trading Activity - Stock Titan
Solventum (NYSE: SOLV) director converts 3,403 RSUs into common stock - Stock Titan
Director at Solventum (NYSE: SOLV) exercises 3,403 RSUs into shares - Stock Titan
Director at Solventum (SOLV) acquires 3,403 shares via RSU exercise - Stock Titan
Director at Solventum (SOLV) exercises 3,403 RSUs into stock - Stock Titan
Solventum (SOLV) director converts 3,403 RSUs to common stock, holds 8,947 shares - Stock Titan
Solventum (SOLV) director converts 4,916 RSUs into Common Stock holdings - Stock Titan
Solventum (SOLV) director Carlos Alban settles 3,403 RSUs into common stock - Stock Titan
Solventum stock is recovering: What's going on? - MSN
Peltz's Trian urges Solventum to rightsize costs, divest non-core businesses - Reuters
Solventum gains on report activist Trian sends letter urging changes - MSN
Vanguard Group Inc. Reduces Holdings in Solventum Corporation $SOLV - MarketBeat
Peltz’s Trian urges Solventum to rightsize costs, divest non-core businesses - WHTC
Jennison Associates LLC Has $49.59 Million Holdings in Solventum Corporation $SOLV - MarketBeat
How The Solventum (SOLV) Narrative Is Shifting With Mixed Analyst Targets And Model Resets - Yahoo Finance
Nelson Peltz Turns Up The Heat On Solventum’s Turnaround - Finimize
Solventum Corp. stock rises Thursday, outperforms market - MarketWatch
Solventum gains after activist Trian sends letter urging changes (update) (SOLV:NYSE) - Seeking Alpha
Trian calls for changes at Solventum after spin-off - Investing.com UK
Trian Urges Solventum to Create Value in Letter to Board - marketscreener.com
Trian Urges Solventum to Create Value in Open Letter to Board - marketscreener.com
Solventum Stock Is Recovering: What's Going On? - Benzinga
Trian pushes Solventum for cost cuts, portfolio review - Investing.com UK
Trian calls on Solventum board to ‘drive value creation’ - TipRanks
Trian urges Solventum to rightsize costs, divest non-core businesses - marketscreener.com
Trian pushes Solventum for cost cuts, portfolio review By Investing.com - Investing.com India
Trian calls for changes at Solventum after spin-off By Investing.com - Investing.com India
Trian Calls on Solventum's Board to Create Value; Publishes Open Letter and Slide Deck - The Manila Times
Vanguard files Schedule 13G: Solventum Corp (SOLV) 10.88M shares disclosed - Stock Titan
Solventum Corporation (NYSE:SOLV) Given Average Rating of "Hold" by Analysts - MarketBeat
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
Is Solventum (SOLV) Offering Value After Its Recent Spin Off From 3M - simplywall.st
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Solventum (SOLV) Projected to Post Earnings on Tuesday - MarketBeat
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
A Look At Solventum (SOLV) Valuation As Recent Trading Performance Draws Investor Attention - simplywall.st
Here's Why Solventum (SOLV) is a Strong Value Stock - Yahoo Finance
KeyBanc Adjusts Price Target on Solventum to $92 From $99, Maintains Overweight Rating - marketscreener.com
Ensemble and Solventum to launch autonomous coding solution for hospitals - MSN
Solventum Corporation (SOLV) Stock Analysis: Unveiling a 23.56% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
B. Metzler seel. Sohn & Co. AG Has $711,000 Stake in Solventum Corporation $SOLV - MarketBeat
Here's why you should hold Solventum stock in your portfolio now - MSN
Solventum Reports Second Quarter 2025 Financial Results - Quantisnow
A Look At 3M (MMM) Valuation After Q1 2026 Earnings And Solventum Spin Off Stabilization - simplywall.st
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):